Optimax Titanium-nitric Oxide-coated Stent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Optimax Titanium-nitric Oxide-coated Stent, covering 2025-06-15 to 2025-06-15. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Safety and Efficacy of Titanium-nitric Oxide-coated Stent (Optimax®) in Patients With Lesions With a Low Risk of Restenosis (Diameter ≥ 3.0 mm and Length ≤ 20 mm)